Skip to main content
    A

    Arcturus Therapeutics Holdings Inc (ARCT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.97
    -0.34 (-4.09%)

    Market Cap: $240.96M

    Last updated: Nov 17, 2026 at 4:34 PM ET

    Arcturus Therapeutics Holdings Inc (ARCT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Arcturus Therapeutics Holdings (ARCT) has a latest price of $7.97 on Nov 17, 2026, 55.6% below its 52-week high of $17.96. Its price rose 9.6% over the past 12 months. The month-end price fell 17.9% over the 10 years through Oct 2026, a compound annual decline of 2.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $91.76 in Nov 2020 and its lowest $4.53 in Dec 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ARCT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ARCT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 22.5%, and over 6 months it rose 19.1%. The month-end price fell 42.3% over the 3 years through Oct 2026, a compound annual decline of 16.7%.

    PeriodChange
    1 month-23.5%
    3 months-22.5%
    6 months+19.1%
    12 months+9.6%
    12 months, with dividends+9.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-42.3%-16.7%
    5 years-75.5%-24.5%
    10 years-17.9%-2.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 299.1%, and its weakest was 2025, when it fell 63.9%.

    YearCloseChange
    2026 through Oct 2026$11.03+79.9%
    2025$6.13-63.9%
    2024$16.97-46.2%
    2023$31.53+85.9%
    2022$16.96-54.2%
    2021$37.01-14.7%
    2020$43.38+299.1%
    2019$10.87+140.0%
    2018$4.53-43.0%
    2017$7.95-45.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 34.3% below its 50-day average of $12.13 and 12.5% below its 200-day average of $9.11.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.97
    52-week high$17.96-55.6%
    52-week low$5.50+44.9%
    50-day average$12.13-34.3%
    200-day average$9.11-12.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 87.5%.

    MeasureValue
    1-year beta2.07
    Largest fall, 1 year-52.9%
    Largest fall, 3 years-87.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ARCT

    What is ARCT's 1-year price change?

    Arcturus Therapeutics Holdings's price rose 9.6% over the past 12 months. With dividends included, the 12-month total return was 9.6%.

    What is ARCT's 5-year price change?

    Arcturus Therapeutics Holdings's month-end price fell 75.5% over the 5 years through Oct 2026, a compound annual decline of 24.5%. These figures leave out dividends.

    What is ARCT's 52-week high and low?

    Arcturus Therapeutics Holdings's 52-week high is $17.96 and its 52-week low is $5.50. Its latest price of $7.97 on Nov 17, 2026 is 55.6% below the high.

    What is ARCT's beta?

    Arcturus Therapeutics Holdings's 1-year beta against the S&P 500 is 2.07, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 52.9%.

    Is the ARCT chart free?

    Yes. Advanced Charting for ARCT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.